Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
3D Printing of Pharmaceuticals and Drug Delivery Devices
| 3D Printing of Pharmaceuticals and Drug Delivery Devices |
| Autore | Lamprou Dimitrios A |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (436 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
3D bio-inks
3D bio-printing 3D bioprinting 3D printed drug products 3D printed oral dosage forms 3D printing acetaminophen additive manufacturing amorphous solid dispersion anti-infective devices antioxidant materials aspirin (acetylsalicylic acid) beads biodegradable biofilm formation bioprinting chemical modification chronotherapeutic delivery complex structures computer-aided design (CAD) computer-aided design (CAD) design controlled release cyclodextrin digital light processing technology digital pharmacy dissolution kinetics drug delivery drug development drug release extrusion extrusion-based 3D printing feature size filament extrusion fixed dose combination fixed-dose combinations floating systems FMD fused deposition modeling fused deposition modeling (FDM) fused deposition modeling 3D printing Fused Deposition Modeling 3D Printing fused deposition modelling fused filament fabrication fused layer modeling gastric floating gastro-retentive floating system geometry gums high API load high-precision targeting hospital pharmacy hot-melt extrusion implantable devices implantable scaffold inkjet printing lignin materials mechanical properties micro-implant micro-swimmer micromedicine microneedle modified drug release modified release MTT assay multiple units multiple-layer dosage forms neural networks on-demand manufacturing optimization oral dosages oral powder orodisperible films orodispersible discs orodispersible film paracetamol (acetaminophen) patient-specific pectin pediatric pelvic organ prolapse personalised medicines personalized medicine personalized medicines personalized pharmaceuticals pharmaceutical quality control pharmaceuticals pharmaceutics pharmacoprinting photopolymerization polylactic acid polymeric ink polymers poor solubility prediction pregabalin pressure-assisted microsyringe (PAM) printlets process processing parameters prolonged drug delivery propolis pseudo-bone pulsatile release release profile resolution semisolid extrusion 3D printing solid dosage forms spheroids stencil printing stereolithography stress urinary incontinence structural design subcutaneous sustained drug release tablets tablets telemedicine theophylline three dimensional printing three-dimensional printing vaginal meshes vascularization vat polymerisation warfarin wound dressing wound-healing |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557780703321 |
Lamprou Dimitrios A
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
| Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside |
| Autore | Tagit Oya |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (296 p.) |
| Soggetto topico |
History of engineering and technology
Materials science Technology: general issues |
| Soggetto non controllato |
3D culture
amine angiotensin animal model anti-inflammatory antigen release atorvastatin calcium biocompatible biodegradable blood-brain barrier (BBB) brightness cancer cardiovascular carrageenan induced inflammation central nervous system chemoimmunotherapy chitosan clinical translation confocal microscopy coumarin 6 current Good Manufacturing Practice (cGMP) Cy5.5 cytotoxicity design of experiments DiI double emulsion solvent evaporation double-emulsion method downstream processing drug delivery drug delivery system drug release drug release kinetics modeling dry powder inhalation emulsion encapsulation ester and acid-end capped fluorescent labeling Food and Drug Administration (FDA) H. pylori immune checkpoint blockade immunogenic cell death in vitro in vivo neuroimaging Indomethacin inline sonication intracellular internalization JO-4 Katushka lyophilization mas receptor methotrexate micro-implant microfluidic microfluidics minimally invasive morphology nanomedicine nanoparticle nanoparticles nanotechnology neurodegenerative diseases neuroprotective drugs nuclear medicine orthotopic tumors particle-size PEGylation pharmacokinetics (PK) and biodistribution photothermal therapy phthalocyanine PLA/PLGA PLGA PLGA diblock copolymer PLGA nanoparticles Pluronic triblock copolymer PNA5 glycopeptide poly (lactic-co-glycolic acid) (PLGA) poly(lactic-co-glycolic acid) poly(lactic-co-glycolic acid) (PLGA) poly(lactic-co-glycolic) acid poly(lactide-co-glycolide) polymeric nanoparticles polyvinyl alcohol (PVA) porous PLGA particles quantum yield radiolabeled nanoparticles rhodamine 123 scale-up manufacturing size SKOVip-kat solid-state characterization solvents spheroids stability of fluorescent label stabilizers sucrose sustained release tangential flow filtration trehalose TurboFP635 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease |
| Record Nr. | UNINA-9910580215803321 |
|
Tagit Oya
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||